Table 3.
Total (n = 1197) % (95% CI) |
Breast (n = 292) % (95% CI) |
Prostate (n = 289) % (95% CI) |
Colorectal (n = 305) % (95% CI) |
Gynecologic (n = 311) % (95% CI) |
|
---|---|---|---|---|---|
Side effects and symptoms | 75.8 (72.1, 79.1) | 77.2 (69.5, 83.4) | 83.1 (76.8, 88.0) | 61.9 (53.6, 69.6)* | 76.1 (67.7, 82.8) |
Tests and treatments | 71.5 (67.5, 75.2) | 71.7 (63.6, 78.5) | 78.0 (70.2, 84.1) | 60.8 (52.5, 68.5) | 71.3 (62.7, 78.6) |
Health promotion | 64.5 (60.3, 68.4) | 66.4 (58.3, 73.6) | 72.4 (64.5, 79.1) | 50.9 (43.0, 58.9)* | 62.3 (53.1, 70.6) |
Interpersonal and emotional | 60.2 (56.0, 64.2) | 63.6 (55.7, 70.9) | 64.7 (56.5, 72.1) | 46.0 (38.5, 53.8)* | 64.2 (55.6, 72.0) |
Insurance | 39.0 (35.0, 43.1) | 40.1 (33.0, 47.6) | 44.0 (35.8, 52.5) | 30.3 (23.9, 37.5) | 38.0 (30.9, 45.6) |
Sexual functioning and fertility | 34.5 (30.6, 38.7) | 22.1 (16.5, 29.0)* | 54.7 (46.1, 63.0)* | 22.5 (16.6, 29.8)* | 23.7 (18.3, 30.2)* |
Significantly different from total (P < 0.05).